John-Bjarne Hansen Selected Research

Length of Stay

10/2022

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John-Bjarne Hansen Research Topics

Disease

44	Venous Thromboembolism 01/2024 - 05/2009
18	Neoplasms (Cancer) 01/2023 - 01/2013
13	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 06/2008
11	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 09/2009
10	Atherosclerosis 01/2021 - 04/2008
10	Myocardial Infarction 12/2019 - 05/2006
9	Inflammation (Inflammations) 04/2022 - 07/2006
6	Thrombosis (Thrombus) 01/2024 - 07/2004
6	Hemorrhage 01/2023 - 01/2018
6	Atherosclerotic Plaque (Atheroma) 01/2018 - 07/2004
5	Pulmonary Embolism 07/2023 - 10/2019
5	Ischemic Stroke 07/2020 - 01/2018
5	Hyperlipidemias (Hyperlipidemia) 11/2018 - 10/2010
4	Obesity 08/2023 - 12/2021
4	Wounds and Injuries (Trauma) 07/2023 - 01/2019
4	Infections 07/2023 - 01/2018
3	Overweight 08/2023 - 01/2010
3	Hypertension (High Blood Pressure) 12/2021 - 02/2012
3	Polycythemia (Erythrocytosis) 05/2012 - 10/2005
3	Carotid Artery Diseases 04/2012 - 07/2008
3	Vascular Calcification 12/2011 - 05/2006
3	Carotid Stenosis (Carotid Artery Stenosis) 03/2008 - 07/2006
2	Hypoxia (Hypoxemia) 01/2023 - 10/2005
2	Stroke (Strokes) 01/2019 - 01/2016
2	Atrial Fibrillation 03/2014 - 12/2012
2	Bone Resorption 08/2012 - 04/2011
2	Adenoma (Adenomas) 05/2012 - 01/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2008 - 06/2008
2	Necrosis 03/2007 - 05/2006
1	Hereditary Angioedemas 11/2023
1	Brain Infarction 10/2022
1	Dehydration (Water Stress) 10/2022
1	COVID-19 08/2022
1	Thrombophilia 01/2022

Drug/Important Bio-Agent (IBA)

12	C-Reactive ProteinIBA 10/2022 - 07/2006
10	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2012
9	AnticoagulantsIBA 01/2023 - 09/2009
8	Thromboplastin (Tissue Factor)IBA 01/2024 - 07/2004
8	fibrin fragment D (D-dimer)IBA 01/2023 - 12/2016
8	Triglycerides (Triacylglycerol)IBA 01/2016 - 06/2008
7	OsteoprotegerinIBA 02/2017 - 05/2006
6	Thrombin FDA Link 11/2023 - 01/2008
6	vinyltriethoxysilane (VTES)IBA 08/2023 - 04/2014
6	Complement System Proteins (Complement)IBA 01/2023 - 01/2018
5	HDL CholesterolIBA 01/2017 - 06/2008
5	Lipoproteins (Lipoprotein)IBA 01/2013 - 06/2008
5	LipidsIBA 05/2012 - 04/2008
5	Testosterone (Sustanon)FDA Link 02/2011 - 07/2008
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2012
4	CholesterolIBA 01/2016 - 02/2012
3	MicroRNAs (MicroRNA)IBA 01/2024 - 09/2015
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2022 - 01/2018
3	Erythropoietin FDA Link 05/2012 - 10/2005
3	Hemoglobins (Hemoglobin)IBA 02/2010 - 10/2005
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2008 - 04/2008
2	Factor VIII (Coagulation Factor VIII)IBA 10/2023 - 01/2021
2	ORALIT (ORS)IBA 01/2023 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
2	HomocysteineIBA 10/2022 - 05/2006
2	Phospholipids (Phosphatides)FDA LinkGeneric 05/2022 - 12/2021
2	Hemostatics (Antihemorrhagics)IBA 04/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2019
2	von Willebrand FactorIBA 12/2021 - 12/2021
2	Fibrinogen (Factor I)FDA Link 01/2021 - 07/2006
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2019 - 01/2019
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2019 - 01/2019
2	Fish OilsIBA 01/2018 - 06/2014
2	factor V LeidenIBA 01/2018 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 03/2014 - 12/2012
2	HDL LipoproteinsIBA 12/2012 - 06/2008
2	CytokinesIBA 08/2012 - 04/2011
2	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2011 - 07/2008
2	Cholecalciferol (Vitamin D3)FDA Link 05/2010 - 01/2010
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024
1	BradykininIBA 11/2023
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 07/2023
1	P-SelectinIBA 01/2023
1	InterleukinsIBA 01/2023
1	ChemokinesIBA 01/2023
1	ThrombomodulinIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Vancomycin FDA LinkGeneric 04/2022
1	LipopolysaccharidesIBA 04/2022
1	LeptinIBA 04/2022
1	Hormones (Hormone)IBA 04/2022
1	EnzymesIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 12/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2021
1	Fibrinolysin FDA Link 01/2021

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
2	Central Venous Catheters 07/2023 - 01/2019
2	Erythrocyte Transfusion 08/2019 - 01/2019
2	Catheters 08/2016 - 09/2009
2	Drug Therapy (Chemotherapy) 01/2014 - 01/2013
1	Blood Transfusion (Blood Transfusions) 07/2023
1	Length of Stay 10/2022